Buy Idea: ARK Genomic Revolution ETF

Research Notes October 2025 > https://www.unum.capital/post/roct2025

Trade Local & Global Financial Markets with Unum Capital.

To get started, email tradingdesk@unum.co.za

Technical recovery in a lagging industry/sector.

The ARK Genomic Revolution ETF (ARKG) is an actively managed fund from ARK Invest that invests in companies involved in the "genomics revolution," such as those in healthcare, information technology, and materials that benefit from technological advances in genomics and related fields. It seeks long-term growth and focuses on companies poised to profit from advances in genomics and life-enhancement technologies.

Buy at current level $29.81 (or better)

Stop-loss: $25.50

Target: $42.00

Lester Davids

Senior Investment Analyst: Unum Capital